TipRanks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market
APLIF
Appili Therapeutics Inc Class A
RESEARCH TOOLSreports

Appili Therapeutics Inc Class A (APLIF) Income Statement

82 Followers

Appili Therapeutics Inc Class A Income Statement

Last quarter (Q1 2027), Appili Therapeutics Inc Class A's total revenue was C$117.89K, an increase of Infinity% from the same quarter last year. In Q1, Appili Therapeutics Inc Class A's net income was C$-1.70M. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
C$ 244.18KC$ 100.44KC$ 827.41KC$ 334.18KC$ 1.39M
Gross Profit
C$ 236.09KC$ 100.44KC$ 827.41KC$ 327.91KC$ 1.39M
Operating Expenses
C$ 6.77MC$ 291.28KC$ 2.92MC$ 8.11MC$ 24.95M
Depreciation and Amortization
C$ 8.08KC$ 13.46KC$ 13.66KC$ 6.27KC$ 12.64K
EBITDA
C$ -6.53MC$ 360.57KC$ -2.07MC$ -8.10MC$ -23.51M
Operating Income
C$ -6.53MC$ -190.84KC$ -2.16MC$ -7.91MC$ -24.68M
Other Income/Expenses
C$ 2.39MC$ -2.42MC$ -1.55MC$ -1.29MC$ -401.36K
Pretax Income
C$ -4.14MC$ -2.61MC$ -3.71MC$ -9.21MC$ -25.08M
Net Income
C$ -4.24MC$ -2.62MC$ -3.78MC$ -9.24MC$ -25.12M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.02C$ -0.03C$ -0.08C$ -0.38
Diluted EPS
C$ -0.03C$ -0.02C$ -0.03C$ -0.08C$ -0.38
Weighted Average Shares Outstanding
 123.72M 121.27M 121.27M 113.73M 66.73M
Weighted Average Shares Outstanding (Diluted)
 123.72M 121.27M 121.27M 113.73M 66.73M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History